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A simple, rapid and practical method for the diagnosis of poliomyelitis has 
long been sought. The neutralization test in monkeys has been too costly for 
routine application  and  has  been  employed primarily as  a  research  tool  in 
studies on the immunology, pathogenesis,  and  epidemiology of  this  disease. 
The important finding of Enders and his associates (1, 2) that the poliomyelitis 
viruses can be cultivated in  tissue  cultures, has permitted the  use of tissue 
culture methods for in vitro  assay of poliomyelitis antibody. A  refinement of 
this technique lies in the recently described metabolic-inhibition test (3). Both 
procedures,  however,  are  relatively  intricate,  require  special  facilities  and 
trained personnel, and do not lend themselves readily to the small laboratory. 
Consequently, some simpler in vitro technique such as the complement fixation 
method would appear desirable. 
Complement  fixation  techniques,  using  infected  mouse  brain  (4--6), cotton  rat 
brain (7-9), and tissue  culture fluids (10-13)  as a source of antigen,  have been de- 
scribed.  Purification (lipoid extraction, ultracentrifugation, methanol precipitation) 
of the rodent brain antigen is required and even so there is considerable difficulty with 
heterotypic fixation with human sera. Also, brain antigens can be prepared only from 
Lansing-like  (Type II) viruses, which are propagable in rodents. The same difficulty 
with heterotypic reactions,  although not to the same extent, has been encountered 
with tissue culture antigens.  Other obstades lie in the fact that in some procedures 
the antigens  require concentration through ultrafiltration  (10) and  the  very small 
amount of concentrated material obtained necessitates  a micro method of conducting 
the complement fixation test; e.g., the method of Fulton and Dumbell (14). Other 
workers  (12, 13) have employed the uneoncentrated tissue culture fluid as a source 
of antigen and also used the drop method of fixation. In the latter case, the avidity 
for complement of the various  test and control antigens,  and of the serum, has to be 
ascertained and the interpretations based on differences in avidity as well as the actual 
titer of the serum (12). 
The complement fixation methods described in the literature are thus beset 
with difficulties associated with heterotypic reactions, and while these can be 
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avoided by certain manipulations, considerable experience is required to avoid 
pitfalls; in addition, the drop method, as is true of any micro method, requires 
more care and  skill than  does a  macro method  in which a  greater margin  of 
error is permissible without unduly affecting the final results. 
We considered,  therefore, that a  macro method would be desirable not only 
because it is more easily and more quickly performed on a large scale, but also 
because the technique of such a  method  is familiar to most workers in clinical 
and public health laboratories. The procedure finally evolved is essentially the 
same  as  that  employed  in  this  laboratory  for  the  routine  diagnosis  of viral 
and  rickettsial  diseases?  The  present  communication  describes  the  test  and 
presents evidence for its sensitivity and specificity as derived from examination 
of patients with poliomyelitis, as well as patients with other neurotropic viral 
infections. 
Materials and Methods 
Specific Antigens.--The  antigens  utilized  in  these  preliminary  studies  consisted  of  un- 
concentrated  fluids harvested  from monkey kidney tissue  cultures  infected  with  poliomy- 
elitis virus. The fluids were obtained from the Connaught Laboratories, and their prepara- 
tion  has  been  described  by  Farrell  eJ  a/.  (15).  The  Type  I  virus  was  represented  by 
the Mahoney strain,  the Type II virus by the MEF-1  strain,  and  the Type HI virus by 
the Sankett strain. 
The potency  of  each  antigen was  determined  in  "checkerboard"  or  "block" titrations 
with hyperimmune monkey serum, and it was found that,  on the whole, the 0.2 ml. of un- 
diluted  tissue culture fluid used in the test represented slightly more than  1 unit,  but less 
than 2 units of antigen, if 1 unit is described as that dilution of antigen which gives three 
plus or four plus fixation with the highest dilution of immune serum. This will be described 
further below under Experimental. 
Control An~igens.--All  sera  were  examined  for  possible  non-specific  complement-fixing 
activity by testing them against a control antigen prepared from the fluid and disintegrated 
ceils of uninfected monkey kidney cultures.  These antigens were used undiluted in 0,2 ml. 
amounts. 
Complement.--Lyophiilzed  complement  was  used  throughout  this  work;  it  was  recon- 
stituted in sterile distilled water as needed. The complement was  titrated  in the presence 
of the specific antigen, and 2 exact units in a  volume of 0.2 ml. were used in the tests. The 
incubation  period for  the  titration  was  1  hour  at  37°C. 
Hemolysln.--2  units  of hemolysin in  0.25  ml.,  as determined  by  titration  at  37°C.  for 
30 minutes with  1:30 complement (0.2  ml.)  and a  2.0 per cent sheep cell suspension  (0.25 
ink), were used. 
Sensitized Ced/s.--Sensitized  cells were prepared by mixing equal volumes of a  2 per cent 
suspension  of sheep erythrocytes and a  dilution of hemolysin containing 2 hemolytic units 
in a volume of 0.25  ml. The mixture was allowed to stand at room temperature for 10 min- 
utes before use. 
1 The details  of the complement fixation method  used  in  this laboratory  are available 
in  mimeographed  form and  will be supplied  on request.  Our  method  is also  described  in 
the chapter on influenza in the forthcoming 2nd edition of Diagnostic Procedures for Viral 
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Sera.--Monkey hyperimmune sera (16) for each of the three immunologic types of virus 
were obtained from The National Foundation for Infantile Paralysis through the courtesy 
of Dr. Henry W.  Kumm and  Dr. Herbert Wenner. These sera, which were in lyophilized 
form, were reconstituted  with physiological saline with due precaution  to maintain steril- 
ity; the reconstituted  serum was kept in the refrigerator at 4°C. These immune sera were 
used as controls in each test and, in addition, high tltered human sera for each of the three 
virus  types were used  as  controls whenever possible. 
The test sera examined in this work came from 37 patients with a  clinical diagnosis of 
poliomyelitis and from 33 patients shown by laboratory methods to be suffering from cen- 
tral nervous system  disturbances  produced by the viruses of Western equine encephalitis, 
St.  Louis encephalitis,  or mumps.  There were  10 individuals with St.  Louis  encephalitis, 
11  with  Western  equine encephalitis,  and  12  with  mumps  encephalitis. 
All sera, after dilution to 1:4 or 1:8 in Kolmer saline solution  s were inactivated at 60"C. 
for 30 minutes. 
Procedure for  Coraploncnt Fixation T~£--Serial  twofold  dilutions  of each  serum  were 
prepared  in Kolmer saline solution,  ffi Each dilution was dispensed into three series of tubes 
so that  tests against each of the three virus types could be run concurrently. In addition, 
the first  two dilutions  of  each  serum  were tested  for anticomplementary  activity in  the 
absence of antigen and for non-specific complement-fixing activity with the control antigen. 
Antigen was then added in a  volume of 0.2 ml. followed by 0.2 rnl. of complement dilution 
containing 2 exact units. Fixation was allowed to proceed at 4°C. overnight (approximately 
18 hours).  The tubes were then warmed in a  37°C.  water bath for 10 minutes, 0.5 mi.  of 
sensitized cells was added  to each tube,  and  secondary incubation at 37°C.  was then con- 
ducted for 15 to 30 minutes, depending upon the time required for the complement control 
tubes to show clearing. The complement controls consisted of a series of four tubes contain- 
ing antigen, sensitized red cells,  and  2 units,  1~ units,  1 unit, or J,~ unit of complement, 
respectively. The tubes containing 1,  1~, and 2 units should show clearing after  15 to 30 
minutes of incubation, and as soon as this occurred the tests were read. The titer of a serum 
was the highest dilution (initial, not final)  showing three plus or four plus fixation with the 
specific antigen. 
EXPERIMENTAL 
Potency of Argigens.--The sensitivity of a  complement fixation method  depends, 
in part,  upon  the potency of  the antigens  employed. The antigenic capacity of the 
infected  tissue  culture  fluids  was  determined  in  "checkerboard"  titrations,  using 
type-specific hyperimmune monkey sera. The results of one such titration, employing 
Type I  tissue culture antigen, are shown in Table I. It will be observed that when the 
fluid was  used  undiluted,  fixation occurred  through  a  serum dilution  of  1:128,  and 
that  when  the fluid was diluted  1:2,  fixation occurred  througb  a  serum dilution  of 
1:32,  i.e.,  this  minimal dilution  resulted  in  a  fourfold  decrease  in  the  serum  titer 
(sensitivity). If 1 unit of antigen is defined as that dilution of the fluid which gives 
4+  or 3+  fixation with  the highest dilution  of immune serum,  then  the undiluted 
tissue culture fluid represented slightly more than  1 unit, but less than 2 units.  The 
fact that the unitage was greater than one is indicated by the appreciable amount of 
fixation which occurred when the fluid was used diluted  1:2. 
2 Kolmer saline solution was used as the diluent for all reagents in the complement fixa- 
tion test, and was prepared by adding 1.0 ml. of 10 per cent magnesium sulfate solution to 
1.0  liter  of 0.85  per  cent  sodium  chloride  solution. 136  POLIOMYELITIS C-F TEST 
Since, for purposes of standardization and for subsequent  comparisons, it is de- 
sirable to know the exact concentration of reagents employed in a  test, several at- 
tempts were made to concentrate the antigen by centrifugation for prolonged intervals 
at  high  speed in  vacuo. While some increase in potency could be achieved, even to 
the extent of obtaining a  preparation that would give 2  units in 0.2  ml., and aside 
from  the fact that the concentrated antigens tended to be slightly anticomplemen- 
tary, the small extent to which the sensitivity of the test was increased did not war- 
rant the labor involved. 
TABLE  I 
Example of Block Titratgon of Antigen, Using Makoney Strain, Type I, Tissue Culture Antigen 
and Homologous Monkey Immune Serum 
Antigen (dilutions  of tissue 
~uA~u~c  uuJuj 
Undiluted 
1:2 
1:4 
None 
Dilutions of monkey immune serum, Type I 
1:16  1:32  1:64  1:128  1:256  1:512 
4*  4  4  4  1  0 
4  3  4-  0  0  0 
0  0  0  0  0  0 
0  0  0  0  0  0 
* 4  =  four-plus fixation, etc. 
TABLE H 
E~e~t of Increasing Con~entragons of Antigen on Extent of Fixation. Makoney Strain,  Type I, 
Virus  Tissue Culture Fluid and Homologous Monkey  lmmune Serum 
Undiluted tissue culture fluid 
antigen 
ml. 
0.1 
0.2 
0.3 
0.4 
None 
1:16 
Dilution of monkey immune serum, Type I 
1:32  1:64  1:128  1:255  1:512 
i 
0  0 
!  o  o 
'  2  0 
1  2  o 
I  0  0 
The possibility was  therefore considered of increasing the  sensitivity of  the  test 
by using larger volumes of undiluted culture fluid; i.e., 0.3 ml. or 0.4 ml. instead of 
the usual 0.2 ml. The results of one of several "checkerboard" titrations, using undi- 
luted  tissue  culture  antigen  and  type-specific monkey  hyperimmune  serum,  are 
shown in Table II. It wiU be noted that 0.1 ml. of antigen gave relatively little fixa- 
tion as compared with that obtained with 0.2 ml. of antigen; with the latter amount, 
there was  an eighffold increase in the serum  endpoint titer as  compared with  the 
former amount.  The use of 0.3 or 0.4 ml. amounts  of antigen did not increase the 
serum titers over those obtained with 0.2 ml.; as will be seen in Table II, the larger 
amounts  of  antigen gave the same degree of fixation as did 0.2  ml.  with serum di- 
luted 1:128, and gave only 2+ fixation with a serum dilution of 1:256. N. J. SCHMrDT  AND  E. H. LENNETTE  137 
While  increasing  the  amount  of  antigen  through  the  use  of larger  volumes  of 
undiluted culture fluid  in the system did not serve to increase  the extent of fixation 
in  the several experiments in which  monkey sera were  employed, the use of larger 
volumes of antigen served, in some instances, to increase the sensitivity of the method 
when human sera were  examined.  This is shown  in Table III, which  presents the 
results  obtained  with  serum  specimens  from  10  patients  with  poliomyelitis when 
the sera were tested against varying amounts of undiluted  tissue culture fluid. The 
amount of fixation obtained with the sera of the first two patients in Table III was 
unaffected by increasing  the amount of antigen in the test. In the case of the next 
four individuals  in the table, the use of larger volumes of antigen resulted in a two- 
fold increase in the serum titers, and in the remaining four patients, the serum titers 
were increased fourfold or more. 
While  the  sensitivity of the  test could  thus  be sharpened,  at least in  some in- 
stances, through the use of 0.3 or 0.4 ml. of the tissue culture antigen, it was found 
that  0.4  ml.  amounts  proved  to  be  undesirably  anticomplementary, and  0.3  ml. 
amounts  were  slightly  anticomplementary.  To  avoid  difficulties  associated  with 
anticomplementary activity, it seemed desirable,  at least in this preliminary work, 
to use only 0.2 ml. of undiluted fluid as the antigen, and the experiments described 
below are all based on the use of this amount. Nevertheless, the data obtained through 
the  use of the  larger volumes of culture  fluid  antigen  suggest that  the  sensitivity 
of the complement fixation method used here couid  be appreciably increased,  if the 
potency of the antigen could  be increased.  Experiments on this aspect are currently 
under way. 
Examination of Sera from Patients with a Clinical Diagnosis  of Poliomyelitis. 
--The preliminary assays described above showed that infected tissue culture 
fluids possessed complement-fixing reactivity when used under conditions that 
would prevail in the complement fixation technique it was desired to employ. 
To gain some information on the usefulness and reliability of this technique 
for the  diagnosis of poliomyelitis, antigens representing  the  three known im- 
munologic types of poliomyelitis virus were used  to  examine paired  or mul- 
tiple serum specimens from 27 patients in whom a  clinical diagnosis of polio- 
myelitis had been made. The findings are presented in Table IV, which  also 
gives the results of complement fixation tests done with the same sera against 
the viruses of mumps, Western equine encephalitis, and St. Louis encephalitis. 
Tests with these latter viruses were performed because the mumps virus is by 
no  means  an  infrequent  incltant  of  central  nervous  system disturbances  in 
California  (17)  and  because,  in  certain parts of the  state,  poliomyelitis, and 
Western  equine and  St. Louis encephalitis are endemic,  and  their seasons of 
prevalence essentially coincide (18). It will be noted that in none of the 26 pa- 
tients from whom sufficient serum was available to perform these  tests,  was 
there any serologic evidence of infection with the viruses of mumps, Western 
equine encephalitis,  or St.  Louis encephalitis.  In every instance but one,  the TABLE HI 
Effect of Increasing  Concentrations  of Poliomyelitis Tissue Culture Antigen  on  the Extoa  of 
Fixation with Human Sera 
Patient 
1.  Do.Kn. 
2.  Mi.Cu. 
3.  Cu.Ho. 
4.  An.Re. 
5.  Su.Me. 
6.  Hu.Po. 
7.  Ka.Ke. 
8.  T.Go. 
9.  M.Su. 
10.  E.Bo. 
Seru~  taken, 
day~ after 
onset 
32 
32 
21 
21 
25 
25 
21 
21 
21 
21 
30 
30 
24 
24 
44 
44 
21 
21 
15 
15 
34 
34 
Amount undiluted 
antlfea 
ml. 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.4 
0.2 
0.4 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
0.3 
0.2 
I  0.3 
0.2 
0.4 
0.2 
0.4 
0.2 
0.4 
0.2 
0.4 
Complement fixation titers 
Type I  !  Type  II  Type III 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
8  <4  <4 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
8  <4  <4 
<4  <4  <4 
<4  <4  <4 
<4  <4  4 
<4  <4  8 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
16  <4  <4 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
16  <4  <4 
32  <4  <4 
64  <4  <4 
<4  <4  <4 
16  <4  <4 
8  <4  <4 
32  <4  <4 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
32  <4  <4 
<4  <4  <4 
<4  <4  <4 
8  <4  <4 
32  <4  <4 
<4  <4  <4 
<4  8  <4 
<4  16  <4 
<4  64  <4 
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complement-fixing titers against these agents were less than 1:8, i.e.,  negativeS; 
the exception was patient 24, whose sera gave slight fixation with the Western 
equine  encephalitis  complement-fixing  antigen,  but  the  antibody  level  en- 
countered  is  not  significant  for Western  equine  encephalitis  and,  moreover, 
there was no rise in titer. 
A  single  stool specimen was available from each  of the  27  patients  listed 
in Table IV. From 12 of these individuals, a  cytopathic agent was recovered 
in  tissue culture  (monkey kidney,  human embryo, or HeLa cells),  identified 
as a  poliomyelitis virus, and typed. In the remaining 15 individuals, attempts 
to isolate an agent from the stool were negative. 
Taking first the  12  individuals  from whom a  poliomyelitis virus was recovered, 
and hence could serve to confirm the serologic findings, it will be noted that in every 
instance the  type of virus recovered from the stool corresponded  with the serologic 
findings.  Thus, 8  individuals  (patients  11  to  18)  showed  a  fourfold  or greater rise 
in  complement-fixing  antibody titer  to  the Type I  virus, and a  Type I  virus was 
recovered from the  stools.  Patient 20,  whose stool yielded a  Type I  virus, showed 
a marked rise in complement-fixing  antibody titer to the same type; he also showed 
a  minimal serologic  response  to Type II virus, but while  the  titer rose slightly at 
this minimal level, it subsequently decreased.  Patient 19, from whose stool a Type I 
virus was recovered,  showed a complement-fixing  titer of 1 : 16 against all three types 
of the poliomyelitis virus. However, examination of the recovery phase serum speci- 
mens showed  that while the titer to Type I virus had remained stationary, the titer 
to Types II and III had decreased.  Patients 21 and 22 showed  a fourfold  or greater 
rise in antibody titer to Types II and III, respectively, which  corresponds  with the 
immunologic  virus  types  recovered from  the  stools  of  these  patients.  In  essence, 
therefore,  an antibody rise  of sufficient  magnitude  to permit diagnosis  occurred in 
11  of  the  12  individuals,  and  in  the  twelfth  individual,  the  homotypic antibody 
response remained at a  stationary level,  the heterotypic antibody level decreasing. 
While  the  number of individuals  examined is  small, in  each case  the  serologic  re- 
sults agreed with the virus isolation  results. 
As concerns  the  15 individuals  in whom a  clinical  diagnosis  of poliomyelitis  had 
been made and from whose  stools  no  virus was recovered,  7  (patients 23,  24,  29, 
30,  34, 36 and 37)  showed  a  fourfold  or greater rise in complement-fixing  antibody 
against the Type I  virus. Patient 28, paralytic, had an antibody tater of less  than 
1:8 to Type II and Type III viruses,  and a stationary titer of 1:32  to the Type I 
virus. Patient 25, also paralytic, had a  titer of less than  1:8 to the Type II virus, 
and an essentially stationary titer to Types I  and III, the titer to the Type I  being 
considerably higher than to the Type III virus. Patient 32 had a  titer of less than 
1:8 to the Type III virus, a fourfold  or higher rise to the Type II virus with a sub- 
sequent decline in the titer, and a relatively high but stationary titer to the Type I 
virus. If any interpretation is permissible on the basis of rdatively high stationary 
titers, .the findings may be interpreted in the case of these three patients as pointing 
to infection  with the Type I  virus. 
3  In the complement fixation test used in this laboratory, the lowest serum dilution ex- 
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TABLE IV 
Results  of Complement  Fixation Tests on Individuals  with a Clinical  Diagnosis  of Poliomyelitis 
Patient  Age 
11. Ti.Go.  I0  mos. 
12. An.Da.  11 mos. 
13. La.Ga.  3 yrs. 
14. Ji.Mo.  5 yrs. 
15.  An.Re.  5 yrs. 
16.  Fr.Ca.  8~ yrs. 
17.  Dw.De.  10 yrs. 
18.  Ge.En.  10 yrs. 
19.  WI.La.  13 yrs. 
20.  Jo.Ho.  25 yrs. 
21.  Ed.Bo.  6 yrs. 
22.  Pa.Ha.  14 mos. 
Virus iso-  IDays I  Clinical type of  lated from  Sex  after,  poliomyelitis 
onset  stool 
M  7 
44 
Paralytic  Type I 
M  4  Paralytic  Type I 
30 
M  5 
10 
15 
Paralytic  Type I 
Poliomyelitis  Neu.rotropic 
VII~d$~S 
compleanent  complement 
fixation  fixation  titers 
titers  against 
]<4  <4  Not 
tested* 
<4  Not 
tested* 
<8  <8 
64  <8 <8 <81 <8 
I 
<8  <8 
<8  <8 
1~  <8  <8  <8  <8 
F  3  Non-paralytic  Type I  <8  <8 <8 
11  1¢  <8  <8  <8  <8 
19  8  <8 <8 <8  <8 
F  7  Paralytic  Type I  <~  <8  I 
21  1¢  <8 <8 <8 <8 
M  7  Non-paralytic  Type I  I<~  <8  I 
20  1128  <8 <8 <8~ <8 
M  9  Paralytic  Type I  <8  <8 
30  64  <8 <8  <8 <8 
F  8  Paralytic  Type I  <8  <8 <8 
21  128  8 <8  <8 <8 
M  2  Abortive  Type I 
15 
Paralytic  Type I 
Paralytic  Type II 
F  4 
34 
43 
M  15 
29 
34 
M  15  Paralytic  Type III 
27 
16  16 <8 
16  8 <8 <8 <8 
<8  16 
128  16'<8 <8 <8 
128  16, <8, <8  <8 
<8  <8 
<8  <8  <8 <8 <8 
<8  <8  <8 <8 <8 
<8  <8 
<8  321 <8  <8  <8 N.  J.  SCHMIDT AND  E.  H.  LENNETTE  141 
TABLE IV--Cor~inued 
Pati~t  Age 
23.  Ma.Su.  31/~ yrs. 
24.  Ca.Re.  31/~ yrs. 
25.  Mi.Ga.  7 yrs. 
26.  Ba.Ca.  7 yrs. 
27.  Mi.Pa.  8 yrs. 
28.  No.Je.  11 yrs. 
29.  Br.Ca.  16 yrs. 
30.  Su.Me.  22  yrs. 
31. Do.Wi.  23 yrs. 
32. Ma.Pi.  23 yrs. 
33. Ea.Ed.  25 yrs. 
Days  Sex  after  Clinical type of 
ionsct  poliomyelltis 
F  7  Nots~ted$ 
F  5 
10 
15 
M  2 
7 
19 
F  7 
10 
21 
Paralytic 
Paralytic 
Non-paralytic 
M  I  Not stated 
12 
M  9  Paralytic 
28 
M  3 
7 
14 
21 
F  4 
21 
F  3 
21 
F  3 
17 
27 
M  4 
14 
27 
Paralytic 
Poliomyelitis  Neu.rotropic 
c~nplement  vtruses 
fixation  ~c°mplement 
fixation titers  Virus iso-  titers  against 
lated from 
stool 
-i 
None  <4 <4 ~:: 
16 <4  <8 <8 <8 
I 
None  <8 <8 <8]  16 
64 <8 <8  8 
64 <8  <8 <8  8<8 
None  32 <8  81 
32 <8  16] 
64 <8  16  i<8<8<8 
None 
None 
None 
None 
Abortive  None 
Not stated  None 
Abortive  None 
Paralytic  None 
<4 <4  <4  <8 
32  16  32  <8 <8 <8 
64  16  64  <8 <8 
<4 <4 <4 
<4 <4 <4  <8 <8 <8 
32 <8 <8 
32 <8 <8  <8 <8 <8 
<8 <8 <81  : 
<8 <8 <8! 
<8 <8 <8 <8 <8 <8 
16 <8 <8  <8 <8 <8 
i  , 
<4 <4 <4i<8: 
16 <4 <4  <8 <8 
i 
<4 <4 <41<8 
<4 <4 <4 <8 <8 <8 
I 
32 <8 <8 <8 
64  16 <8  <8 <8 
32  8 <8  i 
<8 <8 <8 
8 <8 <8 <8 <8 <8 
<8 <8 <8 <8 <8 <8 142  POLIOMYELITIS C-F TEST 
TABLE IV--Continued 
Patient  Age 
34.  Mi.Na.  28 yrs. 
35.  Ro.Un.  29 yrs. 
36. Fr.Tr.  32 yrs. 
37. La.Sc.  34 yrs. 
Sex 
M 
M 
M 
M 
Days 
after 
onset 
3 
14 
21 
44 
60 
3 
13 
5 
7 
11 
21 
Clinical type of 
poliomyelltis 
Non-paralytic 
Non-paralytic 
Paralytic 
Paralytic 
Virus iso- 
lated from 
stool 
None 
None 
None 
None 
Polimnyelitis Neu.rotropic 
complement  v~ruses 
fixation  complement 
titers  fixation tlter~ 
against 
8  4l  4<8 
16 <4  4 
16  4  4<8<8<8 
16  4  41 
32  4  4 
<4 <4 <4  <4 
4 <4  <8 <8 <8 
<4 <4 <4] 
8<4<4  <8 <8 <8 
<8 <8 <~ 
<8  <8 <8 
8<8<~  <8 <8 <8 
128 <8 <8 
* Insufficient serum. 
Not stated,  information not provided by attending physician. 
Patient 26 had a fourfold or greater rise in titer to all three virus types. The sig- 
nificance of the results is difficult to assess since, although fixation with the Type II 
virus might be described as due to a heterotypic response, the rise in antibody titer 
to the Type I  and Type III viruses was of equal magnitude. In the case of patients 
27 and 35, no antibody was demonstrable to any of the three virus types. While it is 
possible  that these patients  did not have poliomyelitis,  it is also possible  that the 
second blood specimen was taken  too early after  the onset of the illness  for anti- 
bodies to have appeared  (the second serum specimens were obtained  12 and 9 days 
respectively after the onset).  In patient 33,  also, the serologic findings were essen- 
tially negative although the individual  was paralyzed,  and  the third  serum  speci- 
men examined was taken 27 days after the onset of the illness.  The findings in the 
fourth individual of the group in whom the serologic results were negative perhaps 
have no bearing on the other findings discussed here since no information could be 
obtained  as  to  the clinical  form of the disease  diagnosed  in  this patient  as polio- 
myelitis, and it is not impossible  that he was suffering from some illness  other than 
poliomyelitis. 
In summary, in this group of 27 individuals,  it was possible in 18 instances 
to make  a  diagnosis  of poliomyelitis  on  the  basis  of a  rise  in  complement- 
fixing  antibody  titer  and,  in  four  additional  individuals,  on  the  basis  of a N,  J.  SCHMIDT  AND  E.  H.  LENNETTE  143 
high  stationary antibody  titer.  In  three  individuals,  no  complement-fixing 
antibodies could be detected in the serum, and in two of these, at least, it is 
possible that the second blood specimen was taken too early after the onset 
of the illness for antibodies to have appeared. In one individual, there was a 
high and equal antibody response to two types of the poliomyelitis virus, and 
in one individual, in whom no antibody was demonstrable, it is not impossible 
that the illness may have been other than poliomyelitis. 
Specificity  of the  Poliomyelitis  Complement  Fixation  Reaction.--The  appli- 
cation of any diagnostic technique to a  new and unknown area requires that 
something be known of the specificity of the reactions encountered.  Conse- 
quently,  the  sera  from  patients  with  central  nervous  system  disturbances 
resulting from infections with the viruses of mumps, Western equine encepha- 
alitis, or St. Louis encephalitis, were tested against the poliomyelitis antigens 
to  ascertain  whether non-specific or  cross-reactions  occur.  The findings are 
presented in Tables V, VI, and VII. 
Table V lists 12 individuals in whom a  serologic  diagnosis of mumps infec- 
tion was made on the basis of a  rise in hemagglutination-inhibiting antibody 
and in complement-fixing antibody to the soluble antigen of the mumps virus. 
It will be observed that 9 of the  12 patients had complement-fixing antibody 
titers of less than 1:4 to all three types of the poliomyelitis virus. The remain- 
ing three patients had stationary titers of  1:4,  1:8,  and  1:16  respectively, 
against  Type  I  poliomyelitis virus.  Such  low  stationary complement-fixing 
antibody titers are encountered in diseases other than poliomyelitis, e.g., influ- 
enza, mumps, Western equine encephalitis, and Q fever, and in our experience, 
have  no  diagnostic  significance  (19)  in  these  diseases.  Whether  the  low 
poliomyelitis  antibody  titers,  however,  represent  residual  antibody  from 
prior  experience with  the  virus, or  are  due  to  an  anamnestic  response,  is 
uncertain at this stage of our knowledge. 
The  results  of poliomyelitis complement fixation tests  on  the  sera  of  11 
individuals in whom a  serologic  diagnosis of Western equine encephalitis had 
been made are  shown in Table  VI.  In  only 2  of these  11  individuals were 
antibodies  against  poliomyelitis virus  encountered,  and  in  both  instances, 
they were against the Type I  virus. One patient, De.Mo., had a  stationary 
complement-fixing antibody titer of 1:8,  a  titer whose significance, as men- 
tioned above, is uncertain from the data thus far available. The other patient, 
K.UI., however, had a rise in titer from less than 1:4 to 1:32; i.e., an eightfold 
or greater rise, and one that is considered significant. While this may quite 
conceivably represent an anamnestic reaction, it would appear more probable 
that  the patient had  suffered a  dual infection with the viruses of Western 
equine encephalitis and of poliomyelitis. The infection in this child was enceph- 
alitic rather than poliomyelitic in nature and suggests that the Western equine 
virus  was  responsible  for  the  symptoms and  physical  signs,  and  that  the 144  POLIOMYELITIS C-F TEST 
TABLE V 
Results of Poliomyditis Complement Fixation Tests on Patients with CNS Disease Caused by 
Mumps Virus 
Patient  Age  Clinical diagnosis 
F.Pe.  2  Mumps encephalomyelitis 
.  Mumps 
Days  complement 
after  fixation 
onset  titer* 
8  <8 
18  32 
Poliomyelitis  com- 
plement  fixation 
tlters 
T~  T~e  Tiy  ~ 
<4  <4  <4 
<4  <4  <4 
L.Cr.  3  Mumps encephalomyelitis  5  <8  4  <4  <4 
15  32  4  <4  <4 
T.Mu.  4  Poliomyelitis  2  <8  <4  <4  <4 
18  32  <4  <4  <4 
M.Da.  5  Mumps  2  16  <4  <4  <4 
21  64  <4  <4  <4 
R.Ma.  6  Mumps meningitis  1  <8  <4  <4  <4 
12  32  <4  <4  <4 
Da.Ti.  7  Mumps encephalomyelitis  3  <8  16  <4  <4 
28  32  16  <4  <4 
Mi.Th,  7  Mumps encephalomyelitis  7  <8  <4  <4  <4 
34  64  <4  <4  <4 
Ro.Se.  7  Poliomyelitis  4  <8  <4  <4  <4 
15  256  <4  <4  <4 
Da.Fr.  8  Mumps  encephalomyelitis;  polio-  4  <8  <4  <4  <4 
myelitis  16  32  <4  <4  <4 
J.Be,  9  Mumps encephalomyelitis  1  <8  <4  <4  <4 
11  32  <4  <4  <4 
J.Ro.  14  Mumps encephalomyelitis  3  <8  8  <4  <4 
13  128  8  <4  <4 
Ru.Ma.  52  Poliomyelitis; encephalomyelitis  1  <8  <4  <4  <4 
14  64  <4  <4  <4 
* Sera were tested against the S (soluble) antigen. 
poliomyelitis virus played a lesser role and perhaps induced only a  subclinical 
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el al.  (20) and by Lennette (21)), in arriving at a  laboratory diagnosis in pa- 
tients  from  geographic  areas  where  two  different  viruses,  each  capable  of 
TABLE VI 
Results of Poliomyel~bis Complement Fixation Tests on Patients with WesternEquine Encephalitis 
Patient 
K.Ta. 
Th.Ma. 
De.St. 
K.Ul. 
Ca.La. 
T.FI. 
I.Ca. 
Fr.Ab. 
Da.Es. 
De.Mo. 
Ha.Ma. 
~e 
I  3 wks. 
r 
1  mo.  ! 
l 
I  6 wks. 
2  mos. 
3  too, 
3 too. 
I 
I  5  too. 
3 yrs. 
8 yrs. 
J 
]  14 yrs. 
I 
67 yrs. 
WEE corn-  Poliomyelitis  complement 
Days  pie.meat  llxation tlte~  Clinical  diagnosis  after  fixation 
onset  titer  Type I  TypeII  Type  III 
Encephalitis  4  <8  <4  <4  <4  <4 
11  128  <4  <4 
Encephalitis  8  < 8  < 4  < 4  < 4 
32  256  <4  <4  <4 
Encephalitis  4  <8  <4  i  <4  <4 
21  128  <4  <4  <4 
Encephalitis  4  <8  <4  [  <4  <4 
40  256  32  i  <4  <4 
I 
Encephalitis  20  <8  <4  <4  <4 
35  128  <4  i  <4  <4 
i 
Encephalitis  3  <8  <4  ]  <4  <4 
41  256  <4  <4  <4 
I 
Encephalitis  5  <8  <4  <4  <4 
16  64  <4  ]  <4  <4 
Encephalitis  3  <8  <4  <4  <4 
14  256  <4  i  <4  <4 
Encephalitis  5  <8  <4  I  <4  <4 
15  128  <4  <4  <4 
Poliomyelitis  3  <8  8  i  <4  <4 
31  256  8  <4  <4 
Encephalitis  1  <8  <4  <4  <4 
14  256  <4  <4  <4 
producing  inapparent  as  well  as  overt  infections,  are  being  disseminated 
concurrently. 
Of the 10 patients with St. Louis encephalitis, 7 had no demonstrable anti- 
body against any of  the  three  types of  poliomyelitis virus. Patient Ra.Aq. 
had  a  stationary titer of  1:8 against the Type I  virus. Patient Ro2ffc.  had 146  POLIOMYELITIS  C-]~ TEST 
the  equivalent  of  a  fourfold  rise  in  titer  to Type  II and  Type  III  viruses. 
However,  in  the  light  of  our  experience  with  the  complement  fixation  test 
in  other  neurotropic  virus  diseases,  interpretation  of a  fourfold  rise  in  titer 
TABLE VH 
Results of Poliomyditis  Complement Fixation Tests on Patients with St. Louis Encephalitis 
SLE corn- 
Days  l~lement 
Patient  Age  Clinical diagnosis  after  fixation 
onset  titer 
~yf  S . 
Ra.Li.  2  Encephalitis;  poliomyelitis 
De.Br.  3  Encephalitis 
G.Wa.  7  Poliomyelitis 
Ja.Be.  9  Poliomyelitis 
Ra.Aq.  10  Encephalitis;  poliomyelitis 
Ro.Mc.  21  Encephalitis 
Wi.F1.  42  Encephalitis;  poliomyelitis 
Jo.Ma.  63  Encephalitis 
AI.De.  69  Encephalitis 
S.Pe.  69  Encephalitis 
Poliomyelitis 
Complement 
fixation titers 
4  <8  <4  <4  <4 
25  64  8  16  16 
3  <8  <4  <4  <4 
14  64  <4  <4  <4 
25  <8  <4  <4~  <4 
44  64  <4  <4  <4 
3  <8  <4  <4  !  <4 
18  64  <4  <41  <4 
/ 
4  <8  8  <4  t  <4 
19  64  8  <4  f  <4 
L 
8  <8  <4  <4  I <4 
25  128  4  8  i  8 
i ! 
6  <8  <4  <4  <4 
14  128  <4  <4  <4 
4  <8  <4  <4  <4 
21  128  <4  <4  <4 
I 
4  <8  <4  <4  i  <4 
12  64  <4  <4  t  <4 
20  32  <4  <4  [  <4 
28  128  <4  <4  <4 
as  a  positive,  at  these  borderline  levels,  requires  caution  (19),  especially  in 
the absence of a  clinical and epidemiologic history on the patient,  or absence 
of  other,  confirmatory  laboratory  evidence.  Patient  Ra.Li.  had  at  least  a 
fourfold rise in titer to the Type I  virus, and at least an eight/old rise to both 
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at the low levels indicated, suggests either an anamnestic response or even a 
dual infection with the viruses of St. Louis encephalitis and of poliomyelitis, 
the sera  giving fixation not only against the infecting type of poliomyelitis 
virus but also against the heterologous types. 
It would appear from these limited experiments that the complement fixa- 
tion test using poliomyelitis antigens is essentially highly specific for polio- 
myelitis, and that while some specific  fixation may occur with antigens for 
other neurotropic diseases, the fixation consists essentially of stationary titers 
at a low, and diagnostically non-significant, level. Where rises in complement- 
fixing antibody titer to two different viruses, e.g., poliomyelitis and Western 
equine encephalitis, are encountered, it seems more reasonable, in the light 
of present limited information, to attribute such a situation to a dual infection 
rather than to an ananmestic rise in antibody to one agent produced by clini- 
cal infection with another (20, 21). 
DISCUSSION 
From the time of the first isolation of the virus by Landsteiner and Popper 
in  1908, and  until relatively recently, investigations on poliomyelitis have 
been impeded by the fact that the monkey constituted the only reliable means 
for isolation of the virus and for antibody assay. The cumbersomeness and 
costliness of such a diagnostic and epidemiologic tool is well illustrated by the 
train  of events which followed the discovery that  certain Type II viruses, 
dz.,  the  Lansing and  MEF-1  strains,  are  propagable  in  the  Swiss mouse; 
epidemiologic studies especially were amplified and intensified, using the Type 
II virus as a model. The advent of the newer tissue culture techniques served 
further to open whole new approaches to the study of poliomyelitis, since it 
became possible for the first time to cultivate all three known immunologic 
types of the virus outside the animal host and to undertake virus isolation 
attempts and antibody assays on a  scale hitherto impossible. 
Despite the widened scope and the amplitude of the studies made possible 
by these tissue culture methods, the need for a simple in ~itro method of anti- 
body assay, especially for diagnosis, is still compelling. 
The complement fixation test described by Casals et al.  (5), and by LaheUe (9), 
utilized antigens prepared from rodent brains infected with Type II viruses. Despite 
purification, however, the use of brain antigens was attended with the occurrence of 
considerable  heterotypic fixation.  Subsequent  investigators  turned  their attention 
to tissue culture materials,  not only because the culture  fluid, relatively free of ex- 
traneous proteins,  might prove  to be a source of more potent antigen but also be- 
muse such fluids might provide a source of specific antigen to all three known im- 
munologic types of the virus rather than to only one. 
Svedmyr et al.  (10) found that  tissue  culture  fluids  were comparatively  weak 
as complement-fixing antigens  and resorted  to an ultrafiltration technique  to con- 
centrate the active material.  Concentration,  however, brought about an undesirable 148  POLIO~LITIS  C-F  TEST 
amount of anti-complementary  activity and heterotypic  fixation could not be com- 
pletely  avoided.  Also, the  comparatively  small  amount of  concentrated  antigen 
obtained  from rather large volumes of starting material  made it necessary to uti- 
lize the Fulton-DumbeU technique  of fixation,  with all the difficulties inherent in 
microtecbniques. Melnick  and his associates  (12, 13), using  unconcentrated  tissue 
culture fluid as an antigen and the fixation method of Fulton and Dumbell, expressed 
their results  by a  method which took into account,  and removed from considera- 
tion,  the effects of non-specific or cross-fixation. More  than passing  care  and skill 
are required in the execution of this test. 
The complement fixation test reported on here is essentiaUy the one used 
in this laboratory for large-scale diagnosis of a diversity of viral and rickettsial 
disease.  Since it is, except for minor modifications, essentially the  technique 
used in clinical and public health laboratories, it thus possesses  the not incon- 
siderable advantage of eventually being incorporated (after considerably more 
is known, of course, as to its specificity, accuracy, and reliability with respect 
to poliomyelitis) into the diagnostic routine of the clinical, hospital, or public 
health laboratory. This was considered a  basic desideratum when the  work 
was undertaken and we believe, in the light of the findings reported here, that 
this  objective  is  attainable,  although,  as  just  mentioned, additional inves- 
tigation and experience derived through practical application of the method 
are required. Certainly a more potent antigen is desirable, and it is to be hoped 
that this can be achieved without recourse to concentration methods; experi- 
mental work on this facet of the problem is currently under way. 
One of the major disadvantages of the neutralization test for the  diagnosis 
of poliomyelitis lies in the fact that in this disease as in certain others, e.g., 
Western  equine  encephalitis  (22,  23),  neutralizing  antibody  appears  very 
early, so that by the time the patient is first seen, the titer is at, or near, the 
maximal level and thus renders difficult or impossible the demonstration of 
a  diagnostically significant rise in titer (23).  This does not appear to he true 
of the  complement-fixing antibody since, as will be noted from the  several 
tables  in  this report,  antibody in  the  acute phase  blood specimen was  not 
demonstrable in a  preponderance  of the  patients,  and when it was  demon- 
strable, it was present at a  very low level. This slow appearance of comple- 
ment-fixing antibody, also noted by others  (6,  11-13),  makes it possible  to 
detect  diagnostic  increases  in  antibody  titer,  and  is  thus  an  advantage  in 
favor of the  complement fixation method as a  diagnostic procedure.  Unfor- 
tunately, as is evident from the several tables, and as has been reported by 
others (6, 11-13), complement-fixing antibody may be rather late in appearing 
so that this advantageous factor is offset by another which militates against 
arriving at a  serodiagnosis relatively early in the disease. 
Little dit~culty was  encountered with heterotypic reactions,  but  it  must 
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small, and the actual extent to which heterotypic reactions might be expected 
must  await  the  results  of a  considerably  wider experience.  With  respect  to 
specificity,  in so far as other neurotropic diseases are concerned,  examination 
of serum specimens from a  small group  of patients  with Western  equine  or 
St. Louis encephalitis, or with mumps encephalitis, indicates that little trouble 
need  be  expected  from  this  quarter.  In  the  three  instances  in  which  there 
was a  rise in complement-fixing antibody  titer not only to  the poliomyelitis 
virus  but  also  to  the  Western  equine  or  St.  Louis  encephalitis  viruses,  the 
possibility of dual infections cannot be ruled out, since the individuals came 
from an area where all three diseases are endemic and the causal viruses are 
disseminated at the same time of the year. In such situations, it is necessary 
not only to set up a battery of serologic tests for a variety of agents, especially 
those known to be operating in the particular area,  but also to attempt iso- 
lation of the virus; on the basis of data derived from such laboratory studies, 
together  with information  obtained  from the  clinical  and  epidemiologic  his- 
tories, it will be possible to appraise the role of each agent in the causation of 
overt  or inapparent  infections and  to obtain  more precise knowledge of the 
epidemiology of the diseases caused by these agents. 
SUM'MARY 
A  macroscopic  (tube)  complement  fixation  test  for  poliomyelitis,  using 
infected tissue culture fluids, is described. 
The  test  was applied  to  27  individuals with a  clinical diagnosis  of polio- 
myelitis.  In  18  patients  it  was  possible  to  make  a  laboratory  diagnosis  of 
poliomyelitis  on  the  basis  of a  rise  in  complement-fixing  antibody  titer  and 
in 4  others on the  basis  of a  high  stationary antibody titer.  One individual 
gave a  high and equal antibody response  to two virus types, 3 others had no 
detectable antibody, and 1 appeared not to have poliomyelitis. 
Heterotypic  reactions  were  encountered,  but gave  little  difficulty  in inter- 
preting homologous responses.  In those patients from whom a virus had been 
recovered,  the serologic findings corresponded  to the virus type recovered. 
The possible occurrence of dual infections with  the viruses of poliomyelitis 
and Western equine and St. Louis encephalitis  is discussed. 
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